Drawing upon cutting-edge biomedical, clinical and machine-learning know-how, we have developed a prototype risk stratification tool, AI_PREMie, for preeclampsia, which affects one in every 10 pregnancies.
AI_PREMie is backed by a multidisciplinary team of experts from the University College Dublin, National Maternity Hospital, the Rotunda Hospital, the Coombe Women’s Hospital, the SAS Institute and Microsoft Ireland.
At present, AI_PREMie is being piloted in three major maternity hospitals* in Dublin, Ireland, capturing 50% of all Irish births. By providing a timely and accurate prognosis, AI PREMie will be a game-changer for women with preeclampsia and should have a major impact on the health and mortality rates of pregnant women and their babies worldwide.
Key Stakeholders:
☆ Prof Patricia Maguire
Scientific Lead, Director of UCD Institute for Discovery, Co-Director of the UCD Conway SPHERE research group.
☆ Prof Fionnuala Ní Áinle
Clinical Lead, Consultant Haematologist, Mater Misericordiae University Hospital & Rotunda Maternity Hospital, Co-Director of the UCD Conway SPHERE research group.
☆ Prof Mary Higgins
Societal Champion, Consultant Obstetrician and Gynaecologist, National Maternity Hospital, Dublin.
AI_PREMie is a UCD Research Group, funded by Science Foundation Ireland (SFI).
*National Maternity Hospital, the Rotunda Hospital, the Coombe Women’s Hospital.
-
Industry
-
Medical and Diagnostic Laboratories
-
Company size
-
11-50 employees
-
Headquarters
-
Dublin
-
Type
-
Nonprofit
-
Specialties
-
Diagnostics, Biochemistry, Medicine, Maternal Health, AI, Machine Learning, Biomarkers, and Platelets
